Targeted Delivery Drugs Market
Targeted Delivery Drugs Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Targeted Delivery Drugs Market Size and Growth
The targeted delivery drugs market is experiencing robust growth, driven by advancements in nanotechnology and personalized medicine. Valued at approximately $134 billion in 2022, it is projected to reach $248 billion by 2030, reflecting a CAGR of 8.4%. Key factors include increasing cancer prevalence and demand for localized treatment options.
Companies Covered
(Covid 19 Impact Covered)
◍ Adverum
◍ Arrowhead Pharmaceuticals
◍ Bayer
◍ Windtree Therapeutics
◍ Immunocore
◍ Mankind Pharma
◍ Roche
◍ Ra Pharma
◍ Keystone Nano
◍ Lipocine
◍ MultiVir
The Targeted Delivery Drugs Market features key players like Adverum, Arrowhead Pharmaceuticals, Bayer, and Roche, utilizing innovative technologies to enhance drug efficacy and reduce side effects. Their advancements in targeted therapies drive market growth. Sales revenues include:
- Bayer: Approximately $50 billion
- Roche: Approx. $60 billion
- Mankind Pharma: ~$1.4 billion.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Other
Request Sample Report
By Product
Ocular Drug Delivery
Pulmonary Drug Delivery
Drug Eluting Stents
Other
Market Growth
Request Sample Report
$ X Billion USD
